Tehran University of Medical Sciences Iranian Journal of Public Health 2251-6085 48 12 2019 12 02 2216 2223 Dariga SMAILOVA Department of Innovations in Science, Semey Medical University, Semey, Republic of Kazakhstan Erlan OSPANOV Department of Neurology, Ophthalmology, and ENT, Semey Medical University, Semey, Republic of Kazakhstan Meruert GAZALIYEVA Department of Clinical Immunology, Allergology, and Microbiology, Karaganda Medical University, Karaganda, Republic of Kazakhstan Dilyara KAIDAROVA Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan Oxana SHATKOVSKAYA Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan Zhanar ZAMANBEKOVA Department of Endocrinology, Semey Medical University, Semey, Republic of Kazakhstan Kuralay AMRENOVA Department of Personalized Medicine, Semey Medical University, Semey, Republic of Kazakhstan Tatyana BELIKHINA Semey Regional Oncology Center, Semey, Republic of Kazakhstan Tasbolat ADYLKHANOV Department of Oncology, Semey Medical University, Semey, Republic of Kazakhstan Ardak OMARBEKOV Department of Surgical Diseases №2, Astana Medical University, Astana, Republic of Kazakhstan Marzhan DAULETYAROVA Research Office, Astana Medical University, Astana, Republic of Kazakhstan Lyudmila PIVINA Department of Emergency Medicine, Semey Medical University, Semey, Republic of Kazakhstan Yuliya SEMENOVA Department of Neurology, Ophthalmology, and ENT, Semey Medical University, Semey, Republic of Kazakhstan 2019 12 02 Background: The incidence and mortality from prostate cancer in most native Asian populations remain low although a gradual increase is observed over the last years. Methods: The statistical analysis of official data on prostate cancer mortality and morbidity was performed for the whole country and for Pavlodar Region. Results: The increase in the incidence of prostate cancer among the population of Kazakhstan is observed, which may be attributed to the introduction of screening program based on serum PSA. Still, the crude incidence rates in Kazakhstan are below world indices. Over the last few years, the decreasing prostate cancer mortality is observed that might be influenced by early diagnosis. The age-standardized incidence rates show that the majority of prostate cancer cases occur in advanced ages (70 years and older). Conclusion: More research is needed to determine the risk factors for prostate cancer, as well as ethnic and geographical trends for the population of Kazakhstan. https://ijph.tums.ac.ir/index.php/ijph/article/view/19073 https://ijph.tums.ac.ir/index.php/ijph/article/download/19073/6603